
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System. The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries
Nurexone biologic (tsxv: nrx)(otcqb:nrxbf)(fse: j90) operates in the Biotechnology research industry.
Nurexone biologic (tsxv: nrx)(otcqb:nrxbf)(fse: j90)'s revenue is 11m - 100m
Nurexone biologic (tsxv: nrx)(otcqb:nrxbf)(fse: j90) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.